QHSLab, Inc. Files 8-K: Regulation FD & Financials

Ticker: USAQ · Form: 8-K · Filed: May 15, 2025 · CIK: 856984

Sentiment: neutral

Topics: 8-K, regulatory-filing, financial-reporting

TL;DR

QHSLab filed an 8-K on 5/15/25 for Reg FD and financials. Formerly USA EQUITIES CORP.

AI Summary

QHSLab, Inc. filed an 8-K on May 15, 2025, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This 8-K filing provides important updates on QHSLab, Inc.'s regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for regulatory and financial disclosures, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for QHSLab, Inc.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on May 15, 2025.

What were some of the previous names of QHSLab, Inc.?

QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.

In which state is QHSLab, Inc. incorporated?

QHSLab, Inc. is incorporated in Nevada.

What is the Standard Industrial Classification code and description for QHSLab, Inc.?

The Standard Industrial Classification code is 3841, and the description is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding QHSLab, Inc. (USAQ).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing